Print Page   |   Contact Us   |   Sign In   |   Register
News & Press: News

Impact Statement - No deal scenario

07 September 2018  
Share |

Impact Statement

 

“BREXIT” – UK government’s preparations for a March 2019 ‘no deal’ scenario

 

Background

The UK Government appears to be increasingly recognising that the outcome of Brexit negotiations in March 2019 could well be a ‘No Deal’ situation. On 23 Aug 2018 therefore the Secretary for Health and Social Care has issued an open letter indicating the UK government’s plans to maintain supply of medicines. These plans basically amount to an edict that pharmaceutical companies should ensure that they have an additional six weeks supply of medicines in the UK on top of their own normal stock levels. In addition the scheme also includes separate arrangements for the air freight of medicines with short shelf-lives, such as medical radioisotopes. This all seems somewhat removed from the previously stated position in mid July 2018 which amounted to a “business as usual” approach.

 

Impact on the downstream UK supply chain

 

It is stated in the Government letter that hospitals, GPs and community pharmacies throughout the UK do not need to take any steps to stockpile additional medicines, beyond their business as usual stock levels. There is also no need for clinicians to write longer NHS prescriptions. Local stockpiling is not necessary and any incidences involving the over ordering of medicines will be investigated. So no impact anticipated for the NHS (as long as industry can continue to supply).

 

Prepared by Malcolm Holmes.

Click here for more information and download


Membership Software Powered by YourMembership  ::  Legal